Stay updated on Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C
Sign up to get notified when there's something new on the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page.

Latest updates to the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record version has been updated from v3.6.5 to v3.6.6, signaling a refreshed version of the page with likely minor edits rather than substantive changes to study details.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page, signaling a new version of the study details page. This reflects a metadata update rather than a change to visible content.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, signaling a small update to the page's metadata.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 for the study details page, indicating a new version of the page's documentation and metadata. This appears to be a non-substantive update rather than changes to the study content or outcomes.SummaryDifference0.0%

- Check76 days agoChange DetectedPage revision label changed from v3.6.0 to v3.6.2, indicating a newer version of the page. This appears to reflect minor maintenance or formatting updates rather than changes to study information.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and normalizes the Intervention/Treatment heading, while indicating recruitment is closed.SummaryDifference0.4%

Stay in the know with updates to Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C
Enter your email address, and we'll notify you when there's something new on the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page.